SDB-006
SDB-006 is a synthetic cannabinoid that belongs to the indazole-3-carboxamide family. It is a designer drug that has been sold online as a "research chemical." SDB-006 is known for its potent agonistic activity at the cannabinoid receptors, specifically the CB1 and CB2 receptors.
Chemical Structure and Properties
SDB-006 has a chemical structure that includes an indazole core, which is a bicyclic structure composed of a benzene ring fused to a pyrazole ring. The full chemical name of SDB-006 is N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide. The molecular formula is C18H26N4O2, and it has a molecular weight of 330.43 g/mol.
Pharmacology
SDB-006 acts as a potent agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system is involved in regulating various physiological processes, including pain sensation, mood, and appetite. The activation of these receptors by SDB-006 can lead to psychoactive effects similar to those produced by tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Legal Status
The legal status of SDB-006 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. In other regions, it may be legal to possess and distribute for research purposes.
Health Risks and Safety
The use of SDB-006 has been associated with various adverse effects, including tachycardia, hypertension, nausea, and anxiety. Due to its potency and the lack of clinical studies, the long-term health effects of SDB-006 are not well understood. Users are advised to exercise caution and be aware of the potential risks.
Related Compounds
SDB-006 is structurally related to other synthetic cannabinoids, such as AB-FUBINACA, ADB-PINACA, and 5F-ADB. These compounds share similar pharmacological profiles and are often found in products marketed as legal alternatives to cannabis.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
